Literature DB >> 22008488

Long-term electrocardiographic follow-up after repair of tetralogy of Fallot.

Martial M Massin1, Sophie G Malekzadeh-Milani, Stefan Schifflers, Hugues Dessy, Thierry Verbeet.   

Abstract

BACKGROUND: Fallot patients with conduction disturbances are prone to sudden cardiac death. However, knowledge about long-term electrocardiographic changes after Fallot repair is limited.
METHODS: Measurements were performed on electrocardiograms recorded preoperatively, postoperatively, and during annual follow-up in 35 Fallot patients included in three groups: G1 if they received no patch (n = 7), G2 if they received a transannular patch (n = 13), and G3 if they received a pulmonary homograft (n = 15).
RESULTS: PR interval increased over the study period in all groups (Z-score: from 0.9 ± 1.1 to 1.3 ± 0.9 in G1, 0.9 ± 1.2 to 1.7 ± 1.6 in G2, and 0.7 ± 0.7 to 1.4 ± 1.3 in G3). The QRS duration increased during the follow-up at a rate of 1.78 msec/year in G1, 2.34 msec/year in G2 despite pulmonary valve replacement in 10 patients, and 1.81 msec/year in G3 despite conduit replacement in 9. At the later follow-up, the QRS duration was significantly increased (Z= 4.5 ± 3.6 in G1, 5.7 ± 1.4 in G2, and 4.6 ± 1.9 in G3). One patient in each group had QRS duration of 170 msec or longer and the one in G3 had a history of serious ventricular arrhythmia. Three patients had a QTc duration above 460 msec.
CONCLUSIONS: Progressive conduction disorders are noted during long-term follow-up in Fallot patients who received transannular patch but also in those who received no patch or a pulmonary homograft. It suggests that volume overloading related to the transannular patch but also pressure overloading and myocardial injury related to surgery contribute to their development. ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22008488      PMCID: PMC6932208          DOI: 10.1111/j.1542-474X.2011.00460.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  18 in total

1.  Reduction of QRS duration after pulmonary valve replacement in adult Fallot patients is related to reduction of right ventricular volume.

Authors:  Bart Hooft van Huysduynen; Alexander van Straten; Cees A Swenne; Arie C Maan; Henk J Ritsema van Eck; Martin J Schalij; Ernst E van der Wall; Albert de Roos; Mark G Hazekamp; Hubert W Vliegen
Journal:  Eur Heart J       Date:  2005-02-16       Impact factor: 29.983

2.  Early and delayed atrioventricular conduction block after routine surgery for congenital heart disease.

Authors:  Angela Lin; William T Mahle; Patricio A Frias; Peter S Fischbach; Brian E Kogon; Kirk R Kanter; Paul M Kirshbom
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-09       Impact factor: 5.209

3.  Prognostic Significance of Quantitative QRS Duration.

Authors:  Aseem D Desai; Tan Swee Yaw; Takuya Yamazaki; Amir Kaykha; Sung Chun; Victor F Froelicher
Journal:  Am J Med       Date:  2006-07       Impact factor: 4.965

4.  Significance of early transient complete heart block as a predictor of sudden death late after operative correction of tetralogy of Fallot.

Authors:  J S Hokanson; J H Moller
Journal:  Am J Cardiol       Date:  2001-06-01       Impact factor: 2.778

5.  Thirty-year electrocardiographic follow-up after repair of tetralogy of Fallot or atrial septal defect.

Authors:  Kent Wall; Hjörtur Oddsson; Britt-Marie Ternestedt; Anders Jonzon; Eva Nylander; Jens Schollin
Journal:  J Electrocardiol       Date:  2006-09-11       Impact factor: 1.438

6.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study.

Authors:  M A Gatzoulis; S Balaji; S A Webber; S C Siu; J S Hokanson; C Poile; M Rosenthal; M Nakazawa; J H Moller; P C Gillette; G D Webb; A N Redington
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

7.  Survival and clinical results up to 26 years after repair of tetralogy of Fallot.

Authors:  H Jonsson; T Ivert
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1995

Review 8.  [Dispersion of ventricular recovery time following surgery for tetralogy of Fallot: correlation with negative prognostic factors].

Authors:  B Sarubbi; G Pacileo; V Ducceschi; C Pisacane; M G Russo; L Santangelo; A Iacono; R Calabrò
Journal:  Cardiologia       Date:  1998-04

9.  Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death.

Authors:  M A Gatzoulis; J A Till; J Somerville; A N Redington
Journal:  Circulation       Date:  1995-07-15       Impact factor: 29.690

10.  Hemodynamic and electrocardiographic effects of early pulmonary valve replacement in pediatric patients after transannular complete repair of tetralogy of Fallot.

Authors:  G Kleinveld; R W Joyner; D Sallee; K R Kanter; W J Parks
Journal:  Pediatr Cardiol       Date:  2006 May-Jun       Impact factor: 1.838

View more
  4 in total

1.  QRS Duration During Follow-Up of Tetralogy of Fallot: How Valuable is it? Analysis of ECG Changes in Relation to Pulmonary Valve Implantation.

Authors:  Thomas Martens; Katrien François; Hans De Wilde; Laurence Campens; Laurent Demulier; Julie De Backer; Daniel Dewolf; Thierry Bove
Journal:  Pediatr Cardiol       Date:  2021-05-07       Impact factor: 1.655

2.  Pulmonic regurgitation and management challenges in the adult with tetralogy of fallot.

Authors:  Emily Ruckdeschel; Joseph D Kay
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

3.  Longitudinal changes in adolescents with TOF: implications for care.

Authors:  Misha Bhat; Laura Mercer-Rosa; Mark A Fogel; Matthew A Harris; Stephen M Paridon; Michael G McBride; Justine Shults; Xuemei Zhang; Elizabeth Goldmuntz
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-03-01       Impact factor: 6.875

4.  QRS Complex Enlargement as a Predictor of Ventricular Arrhythmias in Patients Affected by Surgically Treated Tetralogy of Fallot: A Comprehensive Literature Review and Historical Overview.

Authors:  Pier Paolo Bassareo; Giuseppe Mercuro
Journal:  ISRN Cardiol       Date:  2013-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.